This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers none of which have influenced the event content or the choice of speakers. Sessions delivered with input from these organisations will be marked as such on the programme.

See all sponsors and exhibitors at this event

Sponsored symposium: Navigating the Challenges of Optimising ADHD Medications (MEDICE UK)

Time slot

Tuesday 12 May 2026 - 16:10-16:40

Room

Pharmaceutical Theatre - Exhibition Hall

Session type

Mini-theatre session

Session programme

Professor Bazire will explore different modified-release formulations of stimulants and how this affects bioavailability. He will discuss bioequivalence as it applies to modified-release stimulant preparations and show evidence of treatment disruption when changing modified-release preparations. He will share UK guidance to support prescribing of these medicines and be available to take questions from the audience.

Speaker

Professor Stephen Bazire - Honorary Professor, School of Pharmacy, University of East Anglia, Honorary Consultant Director at Mistura Enterprise and Mistura Informatics

This promotional symposium is organised and sponsored by MEDICE UK and is intended for UK healthcare professionals only. MEDICE UK products will be discussed in this meeting.

UK-ADHD-2026-2928-v1 April 2026

This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers who have provided sponsorship towards this independent programme. They have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the marked sponsored symposia. Sessions delivered with input from these organisations are marked as such on the programme and a list of all sponsors can be found on our sponsor page.

Clinical: Mental health and neurodiversity